EMJ GOLD

From R&D operations to manufacturing efforts, this infographic examines how the pharma sector is being affected by current global instability due to political turmoil and soaring energy prices.

This infographic reflects on the evolution of the biotech sector since 2016, tracking rising revenues, investment cuts and drugs that are making it to market.

This infographic looks at the mission to make an effective vaccine against any virus in just 100 days and explores the diseases that are re-emerging that could be combatted with an expedited approach.

Track the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.

This infographic examines how the pharmaceutical industry’s R&D pipeline is evolving, looking at the companies leading the way and factors behind the recent uptick in IRR.

In the wake of COVID-19, GOLD investigates the potential impact of unpredictable events on the industry’s complex distribution network to understand its resilience and vulnerability.

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?

This infographic explores pharmaceutical trade patterns globally, ranking the top importing and exporting countries, spotlighting the manufacturing hotspots to watch, and investigating the impact of COVID-19 on rates of trade internationally.

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.

This infographic reviews drug launches from recent years, comparing the expectation vs reality of launch, the increase in first-time launchers, and the impact of COVID-19 on the landscape.

We consider the multi-functional uses and potential of biotechnology, highlight some of the biggest players in biotech, and forecast how the market could ascend in the coming years.

This infographic focusses on the three front runners in the COVID-19 vaccine race, uncovering how the race unfolded, comparing the all-important efficacies and characteristics.

In this infographic, we showcase the top performing orphan drug predictions for 2024 and identify the companies leading the way in this space. We also consider the six key steps for orphan drug launch success.

In this infographic, we highlight some of the biggest shifts of the pharmaceutical industry over the past decade, with increased investment and development of biologics, recombinant DNA, and gene research.

We showcase the predictions made for the UK biopharmaceutical workforce, highlighting where additional jobs will be needed and the number of highly skilled or specialist workers that will be required.

As pharma spearheads the search for a COVID-19 vaccine, our infographic reflects on the history of this practice, exploring the diseases and their respective vaccines.

There are many notable initiatives in place by pharmaceutical companies to improve access to medicine around the world, especially in hard-to-reach and developing countries.

Gender parity in the workplace still has a long way to go, and the pharmaceutical industry is no exception, but many companies are taking significant strides in the right direction towards achieving this.

Over the past year investigation into cell therapies has grown markedly, with an estimated 80% increase; the US and China are taking the lead in the development of these therapies, with Europe the closest behind.

This infographic provides an overview of the new molecular entities/new active substances that were approved/recommended for approval by FDA and EMA in 2018.

There are a number of biologic medicines that have come off patent or are due to come off patent in the next few years. Learn more about the intricacies of the biologics market in this infographic.

In this infographic, we have displayed the events and stories that have had a big impact in the world of pharma in 2018. For this, we have focussed on three key areas: M&As, drug approvals, and appointments.

This infographic explores the top-performing drugs of 2017, and looks ahead to those that could triumph nearly a decade later. Find out which drugs are predicted to stay on top, and which others could be on their way down.

Find out about the latest movers and shakers in mergers and acquisitions, including how much money is being made and the pharmaceutical companies that are dominating the M&A space.